Want to see JP:2689 full AI Analyst Report?
OLBA HEALTHCARE HOLDINGS, Inc. (2689) AI Stock Analysis
OLBA HEALTHCARE HOLDINGS, Inc.
(TSE/TYO:2689)
The overall score of 57 reflects a mixed outlook. The company's solid balance sheet and attractive valuation (low P/E, high dividend yield) are positive factors, but these are tempered by weakening profitability, poor cash flow generation, and bearish technical indicators. Financial performance is average, while technicals are weak. The stock appears undervalued, suggesting potential upside if operational improvements materialize.
OLBA HEALTHCARE HOLDINGS, Inc. (2689) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 19.66B
- Dividend Yield
- 4.20%
- Average Volume (3M)
- 3,316
- Price to Earnings (P/E)
- 11.5
- Beta (1Y)
- 0.09
- Revenue Growth
- 2.20%
- EPS Growth
- -31.67%
- Country
- Japan
- Employees
- 1,405
- Sector
- General
- Sector Strength
- 55
- Industry
- Medical - Distribution
OLBA HEALTHCARE HOLDINGS, Inc. Business Overview & Revenue Model
Company Description
OLBA HEALTHCARE HOLDINGS, Inc., founded in 1921 and based in Okayama, Japan, provides an extensive range of healthcare and life science solutions to a diverse clientele across the country. Its customers include medical facilities, academic institutio...
OLBA HEALTHCARE HOLDINGS, Inc. Financial Statement Overview
Summary
Revenue growth has been steady, but margins and net income have declined, with net margin falling to 0.88% in FY2026. Balance sheet is strong with low debt (debt-to-equity 0.22), but cash flow generation is weak, with negative free cash flow. Overall mixed financial health.
Income Statement
48NeutralBalance Sheet
75PositiveCash Flow
35Negative| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 126.60B | 126.60B | 122.70B | 118.56B | 110.47B | 107.96B |
| Gross Profit | 14.18B | 14.18B | 13.91B | 13.60B | 12.95B | 12.50B |
| EBITDA | 2.21B | 2.42B | 2.59B | 2.83B | 2.68B | 2.56B |
| Net Income | 1.11B | 1.11B | 1.43B | 1.50B | 1.41B | 1.54B |
Balance Sheet | ||||||
| Total Assets | 46.65B | 46.65B | 45.87B | 43.24B | 40.88B | 39.97B |
| Cash, Cash Equivalents and Short-Term Investments | 2.64B | 2.64B | 3.47B | 2.73B | 2.40B | 3.19B |
| Total Debt | 2.89B | 2.89B | 2.95B | 1.63B | 1.92B | 1.28B |
| Total Liabilities | 33.59B | 33.59B | 33.62B | 31.86B | 30.55B | 30.88B |
| Stockholders Equity | 13.06B | 13.06B | 12.26B | 11.37B | 10.33B | 9.09B |
Cash Flow | ||||||
| Free Cash Flow | 0 | -388.56M | 181.25M | 1.61B | -910.52M | 1.97B |
| Operating Cash Flow | 0 | 864.57M | 1.63B | 2.08B | -659.52M | 2.42B |
| Investing Cash Flow | 0 | -1.11B | -1.64B | -673.03M | -306.25M | -211.81M |
| Financing Cash Flow | 0 | -590.53M | 686.95M | -1.09B | 175.94M | -1.17B |
OLBA HEALTHCARE HOLDINGS, Inc. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:2689, the sentiment is Negative. The current price of 1903.00 is below the 20-day moving average (MA) of 1915.30, below the 50-day MA of 1912.82, and below the 200-day MA of 1967.75, indicating a bearish trend. The MACD of 0.10 indicates Positive momentum. The RSI at 42.97 is Neutral, neither overbought nor oversold. The STOCH value of 38.20 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:2689.
OLBA HEALTHCARE HOLDINGS, Inc. Peers Comparison
Overall Rating
JP:606270Outperform
JP:707164Neutral- JP:268957Neutral
JP:341752Neutral
JP:926549Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| JP:6062 | 70Outperform | JPY 44.61B | 10.92 | ― | 3.18% | 5.16% | 37.79% |
| JP:7071 | 64Neutral | JPY 38.05B | 11.89 | ― | 1.04% | 6.17% | -33.01% |
| JP:2689 | 57Neutral | JPY 20.14B | 11.55 | ― | 4.20% | 2.20% | -31.67% |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| JP:3417 | 52Neutral | JPY 13.41B | 17.70 | ― | 3.09% | 2.87% | -73.55% |
| JP:9265 | 49Neutral | JPY 8.87B | 15.32 | ― | 3.17% | -0.41% | 2.32% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:2689 | OLBA HEALTHCARE HOLDINGS, Inc. | 1903.00 | -36.60 | -1.89% | |
| JP:3417 | Ohki Health Care Holdings, Inc. | 972.00 | -404.73 | -29.40% | |
| JP:6062 | Charm Care Corporation | 1353.00 | 299.24 | 28.40% | |
| JP:7071 | Amvis Holdings.Inc. | 383.00 | -141.65 | -27.00% | |
| JP:9265 | YAMASHITA HEALTH CARE HOLDINGS, INC. | 3375.00 | 202.90 | 6.40% |
OLBA HEALTHCARE HOLDINGS, Inc. Corporate Events
OLBA Healthcare Profit Slips as Balance Sheet Strengthens Ahead of DVx Integration
OLBA Healthcare Holdings reported consolidated net sales of ¥126,595 million for the fiscal year ended June 30, 2026, up 3.2% year on year, while operating profit fell 15.2% to ¥1,679 million and profit attributable to owners of the parent...
OLBA Healthcare and DVx to Merge via Share Exchange Amid Mounting Sector Pressures
OLBA HEALTHCARE HOLDINGS and DVx Inc. have agreed to a business integration via a share exchange that will make OLBA HEALTHCARE the wholly owning parent and DVx its wholly owned subsidiary, with the transaction scheduled to take effect on September 1...
OLBA Sets Record Date for Vote on DVx Business Integration
OLBA HEALTHCARE HOLDINGS, Inc. has set June 8, 2026, as the record date to determine shareholders eligible to vote at an upcoming extraordinary general meeting. The company will provide notice electronically via its website, establishing which invest...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 17, 2026